3759.HK's Sortino Ratio of 1.14 indicates that for each unit of downside volatility, it generates 1.14 units of excess return. The ratio is calculated using historical daily returns over the past 12 months (as of Jul 18, 2026).
Unlike other measures, Sortino only focuses on downside volatility (losses), making it particularly useful for investors more concerned about protecting against drawdowns than overall price swings.
3759.HK Sortino Ratio Rank
3759.HK ranks above 62.6% of all investments in our database based on Sortino Ratio over the past 12 months, indicating above-average returns relative to downside risk taken. Securities are ranked from 0 (worst) to 100 (best).
What moves the rank
- Strong returns with minimal downside volatility → Higher rank
- Severe or frequent drawdowns → Lower rank
- Upside volatility → No impact (Sortino doesn't penalize upside swings)
What you can do with this information
- Above-average downside protection with room for improvement
- Compare against category peers to gauge relative positioning
- Monitor for movement toward top tier or decline toward median
- Consider pairing with top-tier holdings to improve portfolio risk profile
3759.HK Sortino Ratio Market Positioning
The chart shows 3759.HK's Sortino Ratio relative to all stocks on our platform, with color zones indicating percentile rankings. Higher ratios indicate better downside-adjusted returns.
- Red zone (bottom 25%): -0.40 or lower
- Yellow zone (middle 50%): -0.40 to 1.73
- Green zone (top 25%): 1.73 or higher
- Top 1%: 5.88+
- Median: 0.61 — half of all investments score higher
How it compares to other similar stocks
The table compares Pharmaron Beijing Co Ltd's Sortino Ratio with other stocks in the Biotechnology industry across multiple time periods, showing how 3759.HK's risk-adjusted performance compares to industry peers.
Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jul 18, 2026.
| Symbol | Name | 1Y Sortino Ratio | 5Y Sortino Ratio | 10Y Sortino Ratio | All Time Sortino Ratio |
|---|---|---|---|---|---|
| 2197.HK | Clover Biopharmaceuticals Ltd | 2.88 | |||
| 2162.HK | Keymed Biosciences Inc | 1.64 | |||
| 2269.HK | WuXi Biologics | 1.25 | |||
| 3759.HK | Pharmaron Beijing Co Ltd | 1.14 | |||
| 9995.HK | Remegen Co Ltd | 0.77 | |||
| 1801.HK | Innovent Biologics Inc | 0.39 | |||
| 6160.HK | Beigene Ltd | 0.34 | |||
| 1167.HK | Jacobio Pharmaceuticals Group Co Lt | 0.15 | |||
| 9966.HK | Alphamab Oncology | 0.11 | |||
| 2616.HK | CStone Pharmaceuticals | 0.07 |
Historical Sortino Ratio
The chart shows 3759.HK's rolling Sortino ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to downside risk, while declining trends may signal deteriorating risk-adjusted performance or increased volatility during market stress. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.
Identify market cycles by observing when 3759.HK consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.
Loading charts...
IHow does 3759.HK fit in your portfolio?
Add your other holdings to see your portfolio's Sortino Ratio and find out.
Analyze Your Portfolio